Digital Health Impact 2020

September 30, 2020 9:30 AM - 2:00 PM

Online Conference, Link will be sent in advance of the event.

Add to Calendar 9/30/2020 9:30:00 AM 9/30/2020 2:00:00 PM Digital Health Impact 2020

The convergence between digital health and the life sciences is creating new opportunities to transform patient care as well as drug discovery and development. From wearables to machine learning, digital technologies are easing data collection from patients, increasing medical adherence, supplementing clinical trials, and offering new insights into real-world applications of therapies. Embedding digital health tools into the life sciences will also allow new therapies to better work within the growing value-based healthcare system that relies on data and measurable outcomes.

Join MassBio for our annual Digital Health Impact 2020 event as we examine the current state of digital health as it relates to the life sciences, the challenges facing its growth, and opportunities for collaboration. Through keynotes, panel discussions, and case studies, we’ll explore new strategies for therapeutics and digital health innovators to converge and ultimately deliver better outcomes for patients.

Please contact Laura Rudberg for sponsorship opportunities.

NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

 Online Conference, Link will be sent in advance of the event.
Executive Founder, Wellville
Esther Dyson(@edyson) is executive founder of Wellville (@WaytoWellville), a 10-year nonprofit project (2015-2024) to nudge society towards long-term and equitable thinking by showing the social and financial value of investing in health for all. She is also an active angel investor, focusing on human capital and health (more than “care”), space travel and a variety of useful innovations in areas such as agtech and logistics. Her health investments include 23andMe (former board member), 4D Healthware, Abridge.ai, Big Health, Bioz, Boundless.ai (now owned by Thrive Global), Care.Coach, CareMESH, Clover Health, Devoted Health, Doppel, Eligible, Enso Relief, Epistemic.ai, Ezra.com, Hawthorne Effect, HealthCelerate, HealthTap, i2Dx, MealShare, Medesk, MedicaSafe, mEquilibrium, Mindright, Nanowear, NeuroGeneCES, Nuna, Omada Health, PatientsKnowBest, Pocket Naloxone, Prognos.ai, Proofpilot, Resilient, Solera (also an advisor), StartupHealth, Supportiv, Syllable.ai, Tega Pharmaceutical, Tocagen, Trusty.care, Turbine.ai, Valkee, Virgo, X-VAX and Zipongo. She started her career as a a proofreader, journalist, Wall Street analyst and finally editor/publisher/conference manager (Release 1.0 and PC Forum - 1982-2007). In 1996, she wrote the best-seller “Release 2.0: A design for living in the digital age (Broadway Books). In addition to a Harvard BA in economics, she earned a certificate of completion from the Yuri Gagarin Cosmonaut Training Center (2009) outside Moscow, for her six months of training as a backup cosmonaut.

Brought to you by